3 citations
,
October 2003 in “Annals of Oncology” This case study reported a rare and delayed onset of alopecia in a patient after paclitaxel chemotherapy, potentially influenced by the interaction of thyroid hormones and chemotherapy affecting hair follicle cycles.
2 citations
,
February 2021 in “Endocrinology, diabetes & metabolism case reports” This case report describes a 15-year-old girl with severe hyperandrogenaemia linked to both an ovarian androgen-secreting tumor and HAIR-AN syndrome, highlighting the complexity of diagnosing polycystic ovarian syndrome.
2 citations
,
August 2013 in “Facial Plastic Surgery Clinics of North America” This article reviews strategies for planning and executing follicle graft harvesting using the strip technique, discussing procedural details but reporting no new clinical findings.
2 citations
,
June 1997 in “The American Journal of Cosmetic Surgery” This article discusses methods for camouflaging surgical sites after hair transplant procedures and presents no new clinical findings.
1 citations
,
October 2024 in “BMJ Case Reports” This study highlighted that Sertoli-Leydig cell tumors should be considered in young women with secondary amenorrhea and virilization, and fertility-preserving surgery can be effective when diagnosed early.
1 citations
,
July 2024 in “Human Reproduction” This study found that for obese patients undergoing sleeve gastrectomy, concurrent type 2 diabetes is linked to worsened metabolic but milder reproductive aspects of PCOS and does not hinder the return to regular menstruation one year after surgery.
1 citations
,
December 2022 in “Plants” This study suggests that CSLD1 is key to nitrogen-dependent root hair elongation and regulation of AMT1;2 expression in rice roots.
1 citations
,
September 2022 in “BioNanoScience” This clinical case report describes a patient with ulcerative colitis whose symptoms improved using the Janus kinase inhibitor, tofacitinib, allowing disease remission and hair regrowth.
1 citations
,
August 2022 in “JAMMI” This study found that diverse persistent symptoms are common three months after COVID-19, with older age and hospital diagnosis increasing the likelihood, but early reports may overestimate their prevalence.
1 citations
,
August 2022 in “Case Reports” This case report describes a woman in her 30s who had virilisation and androgenic alopecia due to a testosterone-secreting ovarian tumor, which normalized after its surgical removal.
1 citations
,
January 2021 in “Dermatology Review” This case report describes a young man with bilateral morphea en coup de sabre, which recurred after being quiescent, highlighting its association with previous head trauma and alopecia.
1 citations
,
October 2007 in “International journal of radiation oncology, biology, physics” This study observed that Gamma Knife radiosurgery is generally well tolerated, with some patients experiencing minimal acute complications like scalp numbness and fatigue, and most returning to work shortly after the procedure.
1 citations
,
February 1994 in “Drug Investigation” Sulfasalazine might cause hair loss, especially in women, and stopping it can reverse the hair loss.
July 2026 in “Preprints.org” In this case study, a comprehensive reconstruction approach using autologous fat grafting, follicular unit excision hair transplantation, and scalp micropigmentation led to significant aesthetic and psychosocial improvements in a male patient with severe facial and scalp burn injuries.
April 2026 in “Veterinary Record Case Reports” In this case study, a 2-year-old Pomeranian dog from Mizoram, India, with alopecia X showed significant hair growth and improved skin condition after undergoing neutering and receiving omega-3 and omega-6 fatty acid supplements.
March 2026 in “Lithuanian University of Health Sciences” In this case report, a rare instance of ACTH-independent hypercortisolism in a patient with long-standing Addison's disease led to the discovery of an adrenal cortical adenoma, successfully treated with adrenalectomy, underscoring the importance of considering functional adrenal tumors in such atypical biochemical scenarios.
February 2026 in “Expert Opinion on Pharmacotherapy” This study established consensus-based guidelines for using low-dose oral and topical minoxidil in managing pattern hair loss for patients undergoing hair transplant surgery, recommending specific dosages, monitoring procedures, and timing for initiation post-surgery.
February 2026 in “Contact Dermatitis” This study reports a case of phytodermatitis in a 58-year-old male due to exposure to Axonopus compressus, commonly known as carpet grass, during open defecation, highlighting an unusual cause of contact dermatitis linked to sanitation practices.
September 2025 in “Journal of Medical Case Reports” This study suggests that finasteride may be a safe and effective treatment for androgenetic alopecia in transgender men undergoing testosterone replacement therapy, though it may influence testosterone's effects.
September 2025 in “JAAD Case Reports” Hair extensions can worsen scalp conditions and should be avoided in those with alopecia.
September 2025 in “Journal of the American Academy of Dermatology” Vitiligo may be linked to stopping finasteride.
August 2025 in “International Journal of Women’s Dermatology” In this case series, restarting Janus kinase inhibitors after pregnancy led to hair regrowth in women with alopecia areata, but highlights the lack of standardized treatment guidelines for those planning pregnancy.
August 2025 in “Journal of Cosmetic Dermatology” This study reported significant short-term scalp hair regrowth and increased density in a 4-year-old with Marie Unna hereditary hypotrichosis following topical 5% minoxidil treatment, suggesting its potential benefit in this condition.
July 2025 in “Microscopy and Microanalysis” In this research, scientists developed a compression therapy model using immobilized mice, successfully analyzing skin without causing injury, and observed increased epidermal thickness and changes in adipocyte volume, with no increase in DNA damage markers.
This case report details a 45-year-old woman with SLE who experienced severe leukopenia and hair loss attributed to azathioprine, suggesting the importance of recognizing these potential adverse effects for timely intervention.
July 2025 in “Journal of Cosmetic Dermatology” In this study, authors present a case where a 26-year-old patient with alopecia areata experienced relapse after initially responding to Tofacitinib, mitigated by corticosteroids, highlighting challenges and potential insights into the treatment and pathogenesis of the condition.
April 2025 in “Frontiers in Immunology” This case report describes significant therapeutic effects from Tofacitinib Citrate Sustained-Release Tablets in a patient with Alopecia Areata, while highlighting the economic burden of long-term treatment.
February 2025 in “Clinical Chemistry” This case study reported a 34-year-old woman presenting with secondary amenorrhea, hirsutism, and obesity showed elevated testosterone and anti-Müllerian hormone levels, leading to the exclusion of nonclassical congenital adrenal hyperplasia as a diagnosis.
January 2025 in “JCEM Case Reports” In this case report, a 21-year-old woman diagnosed with ACTH-independent Cushing syndrome showed improvement in symptoms, including a more regular menstrual cycle and lower hirsutism, after starting treatment with ketoconazole, although she developed hypertension.
November 2024 in “Rheumatology Advances in Practice” Rheumatology clinics should always provide preconception counseling for women on DMARDs.